AAAAAA

   
Results: 1-10 |
Results: 10
No association between human herpesvirus 8 and arsenical skin cancers
Authors: Tan, KC Goh, CL Chan, SY Bernard, HU
Citation: Kc. Tan et al., No association between human herpesvirus 8 and arsenical skin cancers, INT J DERM, 40(4), 2001, pp. 303-304
Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides
Authors: Beerheide, W Sim, MM Tan, YJ Bernard, HU Ting, AE
Citation: W. Beerheide et al., Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides, BIO MED CH, 8(11), 2000, pp. 2549-2560
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA
Authors: Stunkel, W Huang, ZH Tan, SH O'Connor, MJ Bernard, HU
Citation: W. Stunkel et al., Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA, J VIROLOGY, 74(6), 2000, pp. 2489-2501
The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element
Authors: O'Connor, MJ Stunkel, W Koh, CH Zimmermann, H Bernard, HU
Citation: Mj. O'Connor et al., The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element, J VIROLOGY, 74(1), 2000, pp. 401-410
Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53
Authors: Zimmermann, H Koh, CH Degenkolbe, R O'Connor, MJ Muller, A Steger, G Chen, JJ Lui, Y Androphy, E Bernard, HU
Citation: H. Zimmermann et al., Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53, J GEN VIROL, 81, 2000, pp. 2617-2623
Potential drugs against cervical cancer: Zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein
Authors: Beerheide, W Bernard, HU Tan, YJ Ganesan, A Rice, WG Ting, AE
Citation: W. Beerheide et al., Potential drugs against cervical cancer: Zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein, J NAT CANC, 91(14), 1999, pp. 1211-1220
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300
Authors: Zimmermann, H Degenkolbe, R Bernard, HU O'Connor, MJ
Citation: H. Zimmermann et al., The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300, J VIROLOGY, 73(8), 1999, pp. 6209-6219
Characterization of an E1A-CBP interaction defines a novel transcriptionaladapter motif (TRAM) in CBP/p300
Authors: O'Connor, MJ Zimmermann, H Nielsen, S Bernard, HU Kouzarides, T
Citation: Mj. O'Connor et al., Characterization of an E1A-CBP interaction defines a novel transcriptionaladapter motif (TRAM) in CBP/p300, J VIROLOGY, 73(5), 1999, pp. 3574-3581
The chromatin structure of the long control region of human papillomavirustype 16 represses viral oncoprotein expression
Authors: Stunkel, W Bernard, HU
Citation: W. Stunkel et Hu. Bernard, The chromatin structure of the long control region of human papillomavirustype 16 represses viral oncoprotein expression, J VIROLOGY, 73(3), 1999, pp. 1918-1930
Many different papillomaviruses have low transcriptional activity in spiteof strong epithelial specific enhancers
Authors: Sailaja, G Watts, RM Bernard, HU
Citation: G. Sailaja et al., Many different papillomaviruses have low transcriptional activity in spiteof strong epithelial specific enhancers, J GEN VIROL, 80, 1999, pp. 1715-1724
Risultati: 1-10 |